Critical dissolution tests of oral systems based on statistically designed experiments. II. In vitro optimization of screened variables on ER-coated spheres for the establishment of an in vitro/in vivo correlation.

The study was designed to optimize the effects of the screened in vitro dissolution variables agitation, temperature, osmolality, and polarity on the release of the neuroleptic compound remoxipride from extended release coated spheres. The variables were varied independently by means of a fractional factorial design. The in vitro tests were performed with the Basket method (USP). The polarity and the osmolality of the medium had significant effects on the dissolution rate of remoxipride. A statistical model was calculated based on the obtained dissolution in vitro. The model was then used to predict the in vitro conditions that most closely correlated with the dissolution rate of remoxipride in vivo, after administration of the formulation to 16 volunteers. The predicted in vitro conditions were experimentally verified, and an excellent association with the in vivo behavior of the formulation was found. Validation of the optimal in vitro conditions was performed on another batch of the formulation. The dissolution profile obtained showed a significant association with the corresponding dissolution profile in vivo. The use of statistically designed experiments in the development of critical dissolution tests for the establishment of in vitro/in vivo correlations seems to be a useful working approach, and supports further application to other oral solid systems.

[1]  Stefan Bouckaert,et al.  Optimization of a Granulation Procedure for a Hydrophilic Matrix Tablet Using Experimental Design , 1996 .

[2]  G. Ragnarsson,et al.  In vitro release characteristics of a membrane-coated pellet formulation — influence of drug solubility and particle size , 1992 .

[3]  R. Abuzarur-Aloul,et al.  Critical dissolution tests of oral systems based on statistically designed experiments. I. Screening of critical fluids and in vitro/in vivo modelling of extended release coated spheres , 1997 .

[4]  J. Wagner,et al.  Per cent absorbed time plots derived from blood level and/or urinary excretion data. , 1963, Journal of pharmaceutical sciences.

[5]  J. W. Skoug,et al.  Strategy for the development and validation of dissolution tests for solid oral dosage forms , 1996 .

[6]  A. Höskuldsson.  PLS regression methods , 1988 .

[7]  B. Palsson,et al.  MECHANISM OF RELEASE FROM PELLETS COATED WITH AN ETHYLCELLULOSE-BASED FILM , 1990 .

[8]  E. Johansson,et al.  Validation of an extended release tablet dissolution testing system using design and multivariate analysis , 1994 .

[9]  K. Gjellan,et al.  Use of statistical experimental design in the further development of a discriminating in vitro release test for ethyl cellulose ER-coated spheres of remoxipride , 1996 .

[10]  J B Schwartz,et al.  Computer optimization of pharmaceutical formulations. I. General procedure. , 1973, Journal of pharmaceutical sciences.

[11]  F. Langenbucher.  in vitroとin vivoの薬物利用率を関連づける手段としての数字であらわしたコンボルューションとデコンボルューション , 1982 .

[12]  Tone Østberg,et al.  Calcium alginate matrices for oral multiple unit administration. III: Influence of calcium concentration, amount of drug added and alginate characteristics on drug release , 1994 .

[13]  G. Ragnarsson,et al.  Osmotic pumping as a release mechanism for membrane-coated drug formulations , 1989 .

[14]  A. Badawi,et al.  Optimization of a Reconstitutable Suspension of Rifampicin Using 24 Factorial Design , 1996 .

[15]  G. Amidon,et al.  Determination of the sensitivity of a tablet formulation to variations in excipient levels and processing conditions using optimization techniques , 1987 .

[16]  T. Kararli.  Comparison of the gastrointestinal anatomy, physiology, and biochemistry of humans and commonly used laboratory animals , 1995, Biopharmaceutics & drug disposition.